SCHEMBL440040

SCHEMBL440040

CC(C)C1C=CC(=O)CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 2/20 0.33
MET P08581 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986168 1.00 TLR4 (0.33) TLR4MET
SCHEMBL10412357 0.81
SCHEMBL10412358 0.81
SCHEMBL10413081 0.81
Rel-Menthone SCHEMBL4255703 0.81 TLR4 (0.36) TLR4
Menthol SCHEMBL1579789 0.79 TRPM8 (0.57)
SCHEMBL3851127 0.76 MET (0.34) MET
Citronellol SCHEMBL23645875 0.75 ALOX15 (0.51)
Beta-Phellandrene SCHEMBL17629433 0.74 MET (0.31) MET
Beta-Phellandrene SCHEMBL1306441 0.74 MET (0.31) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1081 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014065-A1 PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF Dewey Beauty LLC (US) 2026-01-15 US claimed
CN-120118846-A Liver cancer organoid culture and Tibetan medicine drug sensitivity detection method based on microfluidic chip 西藏民族大学 2025-06-10 CN claimed
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS BASF SE (DE) 2025-03-20 US claimed
CN-116837040-B Fermented fruit oil and preparation method and application thereof 深圳市仙迪化妆品股份有限公司 2025-02-07 CN claimed
CN-116650366-B Fermentation filtrate and preparation method and application thereof 深圳市仙迪化妆品股份有限公司 2025-01-24 CN claimed
US-20240409705-A1 DECONTAMINATION BATH AND METHOD FOR DECONTAMINATING A PLASTIC ARTICLE SMART COLORING GMBH (DE) 2024-12-12 US claimed
WO-2024187002-A1 FANZORS ARE RNA-GUIDED NUCLEASES ENCODED IN EUKARYOTIC GENOMES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-09-12 WO claimed
US-20240301373-A1 FANZORS ARE RNA-GUIDED NUCLEASES ENCODED IN EUKARYOTIC GENOMES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-09-12 US claimed
CN-118613569-A Compositions comprising 4-isopropyl-1-methyl-7-oxabicyclo [2.2.1] heptan-2-ol or esters or ethers thereof and use thereof as fragrance chemicals 巴斯夫欧洲公司 2024-09-06 CN claimed
EP-4413064-A1 DECONTAMINATION BATH AND METHOD FOR DECONTAMINATING A PLASTIC ARTICLE Smart Coloring GmbH (DE) 2024-08-14 EP claimed
US-20030156728-A1 Speaker-use protection element and speaker device SONY CORPORATION (JP) 2003-08-21 US claimed
US-20030100672-A1 Method for obtaining a stabilized photochromic latex, latex obtained, and application to ophthalmic optics ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE 2003-05-29 US claimed
WO-2002055564-A1 METHOD FOR OBTAINING A STABILISED PHOTOCHROMIC LATEX, LATEX OBTAINED AND USE IN OPHTHALMIC OPTICS ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2002-07-18 WO claimed
EP-0953562-A1 Beta, gamma-unsaturated delta-keto esters Givaudan Roure (International) S.A. (CH) 1999-11-03 EP claimed
US-5567416-A OIL ABSORBING POLYMERIC NETWORK MATERIALS RICOH COMPANY, LTD. (JP) 1996-10-22 US claimed
EP-0424873-A2 Method for modifying the surface of a polymer article Tosoh Corporation (JP) 1991-05-02 EP claimed
US-4639532-A Process for preparing synthetic periplanone-B YALE UNIVERSITY (US) 1987-01-27 US claimed
EP-0185752-A4 PROCESS FOR PREPARING SYNTHETIC PERIPLANONE-B. UNIV YALE (US) 1986-11-06 EP claimed
EP-0185752-A1 PROCESS FOR PREPARING SYNTHETIC PERIPLANONE-B YALE UNIVERSITY (US) 1986-07-02 EP claimed
WO-1986000308-A1 PROCESS FOR PREPARING SYNTHETIC PERIPLANONE-B YALE UNIVERSITY (US) 1986-01-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014065-A1 PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF DHCR24, CNR2, DSG1 TLR4 1718/4885MET 4133/4885
US-20250092331-A1 COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS OXER1, MSMO1, IPO7 TLR4 1793/4885MET 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.